Tenderwize
Back to tender search

Open House Discount Agreements for Colecalciferol (Non-RX) Prescription Products According to Annex 1 AM-RL G-BA, ATC A11CC05

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jan 05, 2027 · 141 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Colecalciferol, non RX, ausschließlich nach Anlage 1 AM-RL G-BA verordnungsfähige Produkte, ATC A11CC05

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

Open-house agreements may be automatically terminated if other discount agreements for Colecalciferol are concluded in...

No minimum volume or revenue guarantee; actual sales depend on prescription behavior.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Feb 2027
  • Supply of Colecalciferol (Vitamin D3) products (non-RX, prescription products according to Annex 1 AM-RL G-BA, ATC A11CC05)
  • Non-exclusive discount agreements under § 130a Abs. 8 SGB V with AOK Bayern
Show full summary

Open-house model for non-exclusive discount agreements on Colecalciferol (non-RX) products for AOK Bayern. All qualified pharmaceutical companies can join. Contracts run from 01/03/2025 to 28/02/2027. No competitive selection; contracts are awarded to all interested and eligible participants.

Risks

Open-house agreements may be automatically terminated if other discount agreements for Colecalciferol are concluded in...

No minimum volume or revenue guarantee; actual sales depend on prescription behavior.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible

Administrative

  • Submission of signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
  • Submission of signed contract and appendix 'Festlegung der vertragsgegenständlichen Arzneimittel'

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open House Discount Agreements for Colecalciferol (Non-RX) Prescription Products According to Annex 1 AM-RL G-BA, ATC A11CC05

Non-exclusive discount agreements for Colecalciferol (Vitamin D3) products, non-RX, prescription products according to Annex 1 AM-RL G-BA. Supply of pharmaceutical products under § 130a Abs. 8 SGB V. Any pharmaceutical company meeting eligibility can join. Contracts are identical and non-negotiable.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Feb 2025 - Feb 2027

Category

Pharmaceutical products

Deadline

Deadline Jan 05, 2027

Procurement Details

Publication date
16 Jan 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
33054-2025

Documents (2)

Similar tenders